AU3878697A – Identification of abnormalities in the expression of t and cell antigen receptors as indicators of disease diagnosis, prognosis and therapeutic predictors
– Google Patents
AU3878697A – Identification of abnormalities in the expression of t and cell antigen receptors as indicators of disease diagnosis, prognosis and therapeutic predictors
– Google Patents
Identification of abnormalities in the expression of t and cell antigen receptors as indicators of disease diagnosis, prognosis and therapeutic predictors
Info
Publication number
AU3878697A
AU3878697A
AU38786/97A
AU3878697A
AU3878697A
AU 3878697 A
AU3878697 A
AU 3878697A
AU 38786/97 A
AU38786/97 A
AU 38786/97A
AU 3878697 A
AU3878697 A
AU 3878697A
AU 3878697 A
AU3878697 A
AU 3878697A
Authority
AU
Australia
Prior art keywords
predictors
prognosis
abnormalities
indicators
therapeutic
Prior art date
1996-06-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38786/97A
Inventor
Kendall A. Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell Research Foundation Inc
Original Assignee
Cornell Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1996-06-20
Filing date
1997-06-19
Publication date
1998-02-02
1997-06-19
Application filed by Cornell Research Foundation Inc
filed
Critical
Cornell Research Foundation Inc
1998-02-02
Publication of AU3878697A
publication
Critical
patent/AU3878697A/en
Status
Abandoned
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
C12Q2600/00—Oligonucleotides characterized by their use
C12Q2600/118—Prognosis of disease development
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
C12Q2600/00—Oligonucleotides characterized by their use
C12Q2600/156—Polymorphic or mutational markers
AU38786/97A
1996-06-20
1997-06-19
Identification of abnormalities in the expression of t and cell antigen receptors as indicators of disease diagnosis, prognosis and therapeutic predictors
Abandoned
AU3878697A
(en)
Applications Claiming Priority (3)
Application Number
Priority Date
Filing Date
Title
US2013896P
1996-06-20
1996-06-20
US60020138
1996-06-20
PCT/US1997/010557
WO1998001738A2
(en)
1996-06-20
1997-06-19
Identification of abnormalities in the expression of t and b cell antigen receptors as disease indicators
Publications (1)
Publication Number
Publication Date
AU3878697A
true
AU3878697A
(en)
1998-02-02
Family
ID=21796965
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU38786/97A
Abandoned
AU3878697A
(en)
1996-06-20
1997-06-19
Identification of abnormalities in the expression of t and cell antigen receptors as indicators of disease diagnosis, prognosis and therapeutic predictors
Country Status (2)
Country
Link
AU
(1)
AU3878697A
(en)
WO
(1)
WO1998001738A2
(en)
Families Citing this family (35)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
GB9710820D0
(en)
*
1997-05-27
1997-07-23
Univ Dundee
Immunological method
JP2006511210A
(en)
*
2002-09-11
2006-04-06
ジェネンテック・インコーポレーテッド
Novel compositions and methods for the treatment of immune related diseases
US20040157242A1
(en)
2002-11-12
2004-08-12
Becton, Dickinson And Company
Diagnosis of sepsis or SIRS using biomarker profiles
CN1738909A
(en)
2002-11-12
2006-02-22
贝克顿迪金森公司
Diagnosis of sepsis or SIRS using biomarker profiles
BRPI0609302A2
(en)
2005-04-15
2011-10-11
Becton Dickinson Co
methods for predicting the development of sepsis and for diagnosing sepsis in an individual to be tested, microarray, kit for predicting the development of sepsis in an individual to be tested, computer program product, computer, computer system for determining if an individual is likely to develop sepsis, digital signal embedded in a carrier wave, and, graphical user interface to determine if an individual is likely to develop sepsis
US8669113B2
(en)
2008-04-03
2014-03-11
Becton, Dickinson And Company
Advanced detection of sepsis
AU2009311588B2
(en)
2008-11-07
2016-07-28
Adaptive Biotechnologies Corp.
Methods of monitoring conditions by sequence analysis
US9528160B2
(en)
2008-11-07
2016-12-27
Adaptive Biotechnolgies Corp.
Rare clonotypes and uses thereof
US9506119B2
(en)
2008-11-07
2016-11-29
Adaptive Biotechnologies Corp.
Method of sequence determination using sequence tags
US8748103B2
(en)
2008-11-07
2014-06-10
Sequenta, Inc.
Monitoring health and disease status using clonotype profiles
US9365901B2
(en)
2008-11-07
2016-06-14
Adaptive Biotechnologies Corp.
Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia
US8628927B2
(en)
2008-11-07
2014-01-14
Sequenta, Inc.
Monitoring health and disease status using clonotype profiles
US8691510B2
(en)
2008-11-07
2014-04-08
Sequenta, Inc.
Sequence analysis of complex amplicons
EP2387627B1
(en)
2009-01-15
2016-03-30
Adaptive Biotechnologies Corporation
Adaptive immunity profiling and methods for generation of monoclonal antibodies
WO2010151416A1
(en)
2009-06-25
2010-12-29
Fred Hutchinson Cancer Research Center
Method of measuring adaptive immunity
US9043160B1
(en)
2009-11-09
2015-05-26
Sequenta, Inc.
Method of determining clonotypes and clonotype profiles
US10385475B2
(en)
2011-09-12
2019-08-20
Adaptive Biotechnologies Corp.
Random array sequencing of low-complexity libraries
EP2768982A4
(en)
2011-10-21
2015-06-03
Adaptive Biotechnologies Corp
Quantification of adaptive immune cell genomes in a complex mixture of cells
EP2788509B1
(en)
2011-12-09
2018-07-11
Adaptive Biotechnologies Corporation
Diagnosis of lymphoid malignancies and minimal residual disease detection
US9499865B2
(en)
2011-12-13
2016-11-22
Adaptive Biotechnologies Corp.
Detection and measurement of tissue-infiltrating lymphocytes
EP3372694A1
(en)
2012-03-05
2018-09-12
Adaptive Biotechnologies Corporation
Determining paired immune receptor chains from frequency matched subunits
US9150905B2
(en)
2012-05-08
2015-10-06
Adaptive Biotechnologies Corporation
Compositions and method for measuring and calibrating amplification bias in multiplexed PCR reactions
ES2660027T3
(en)
2012-10-01
2018-03-20
Adaptive Biotechnologies Corporation
Evaluation of immunocompetence by the diversity of adaptive immunity receptors and clonal characterization
US10150996B2
(en)
2012-10-19
2018-12-11
Adaptive Biotechnologies Corp.
Quantification of adaptive immune cell genomes in a complex mixture of cells
US9708657B2
(en)
2013-07-01
2017-07-18
Adaptive Biotechnologies Corp.
Method for generating clonotype profiles using sequence tags
CA2941612A1
(en)
2014-03-05
2015-09-11
Adaptive Biotechnologies Corporation
Methods using randomer-containing synthetic molecules
US10066265B2
(en)
2014-04-01
2018-09-04
Adaptive Biotechnologies Corp.
Determining antigen-specific t-cells
EP3212790B1
(en)
2014-10-29
2020-03-25
Adaptive Biotechnologies Corp.
Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
US10246701B2
(en)
2014-11-14
2019-04-02
Adaptive Biotechnologies Corp.
Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
AU2015353581A1
(en)
2014-11-25
2017-06-15
Adaptive Biotechnologies Corporation
Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing
ES2858306T3
(en)
2015-02-24
2021-09-30
Adaptive Biotechnologies Corp
Method for determining HLA status by sequencing the immune repertoire
WO2016161273A1
(en)
2015-04-01
2016-10-06
Adaptive Biotechnologies Corp.
Method of identifying human compatible t cell receptors specific for an antigenic target
US10428325B1
(en)
2016-09-21
2019-10-01
Adaptive Biotechnologies Corporation
Identification of antigen-specific B cell receptors
US11254980B1
(en)
2017-11-29
2022-02-22
Adaptive Biotechnologies Corporation
Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements
CN112301099A
(en)
*
2020-11-30
2021-02-02
南方科技大学
Primer group for amplifying B lymphocyte immune repertoire and application thereof
Family Cites Families (1)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US4886743A
(en)
*
1985-04-24
1989-12-12
California Institute Of Technology
Diagnostic reagents based on unique sequences within the variable region of the T cell receptor and uses thereof
1997
1997-06-19
AU
AU38786/97A
patent/AU3878697A/en
not_active
Abandoned
1997-06-19
WO
PCT/US1997/010557
patent/WO1998001738A2/en
active
Application Filing
Also Published As
Publication number
Publication date
WO1998001738A3
(en)
1998-04-30
WO1998001738A2
(en)
1998-01-15
Similar Documents
Publication
Publication Date
Title
AU3878697A
(en)
1998-02-02
Identification of abnormalities in the expression of t and cell antigen receptors as indicators of disease diagnosis, prognosis and therapeutic predictors
AU2815900A
(en)
2000-09-14
Clinical and diagnostic database
AU3501197A
(en)
1998-01-21
Human stem cell antigens, dna coding therefor and their use
ZA9810130B
(en)
1999-05-06
Tumor-specific antigens methods for their production and their use for imunization and diagnosis
AU2991697A
(en)
1997-11-07
Methods of diagnosing clinical subtypes of crohn's disease
WO1997008318A3
(en)
1997-04-17
Compounds and methods for treatment and diagnosis of prostate cancer
AU3182999A
(en)
1999-09-27
Methods of diagnosis and triage using cell activation measures
AU6416198A
(en)
1998-10-30
Diagnostic means useful for predictive assessment of human hepatocellular carc inoma disease (hcc), as well as diagnostic methods using the same
IL110464A0
(en)
1994-10-21
Novel proteins for the diagnosis, imaging, and therapy of human cancer
AU1810899A
(en)
1999-06-28
Neuropilins and use thereof in methods for diagnosis and prognosis of cancer
AU2154297A
(en)
1997-10-01
Microparticles, process for their production, and their use in ultrasound diagnosis
EP1111049A4
(en)
2002-10-29
Novel receptor protein and method for diagnosing inflammatory diseases by using the same
AU1138699A
(en)
1999-05-31
Dna demethylase, therapeutic and diagnostic uses thereof
AU6063900A
(en)
2001-04-10
Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
EP0774970A4
(en)
2000-02-02
Method of using hyaluronic acid for the detection, location and diagnosis of tumors
AU6592896A
(en)
1997-02-18
Analysis of alpha integrins for the diagnosis of diabetic nephropathy
DE69800080T2
(en)
2000-08-24
Antibodies against the prorenin profragment, reninactive substance that contains them and prorenin test that uses them
AU5652799A
(en)
2000-04-10
Method for the diagnosis of cell proliferative disease
DE69516534T2
(en)
2000-11-30
ANTIBODIES AGAINST ALLOGENIC AND XENOGENE PROTEINS, THEIR USE IN DIAGNOSIS AND THERAPY AND METHOD FOR THE DETERMINATION THEREOF
AU1457300A
(en)
2000-05-22
Dna replication-regulating genes, antibodies thereto and diagnostic applicationsthereof
WO1999061909A3
(en)
2000-03-23
Methods and compositions for the detection of human herpesvirus
AU6257998A
(en)
1998-09-22
Methods for diagnosing and treating autoimmune disease
AU5887700A
(en)
2001-04-30
Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
GB9713131D0
(en)
1997-08-27
Assays,therapeutic and diagnostic methods and means
Hoffmann et al.
1997
DANAOS-A European Multi-Center Study on Automated Diagnosis of Skin Cancer.: 064.
None